RELATED STUDY
Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ⁹-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour.
Key Findings: CBD reduced OCD-like behavior in the test animals.
Type of Study: Animal Study
Study Result: Positive
Research Location(s): United Kingdom
Year of Pub: 2012
Cannabinoids Studied: Cannabidiol (CBD), Cannabigerol (CBG), Tetrahydrocannabivarin (THCV)
Phytocannabinoid Source: Unspecified
Dosage: CBD (120 mg/kg, ip and oral)
Route of Administration: Injection, Oral (Ingestion)
Citation: Deiana S, et al. Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ⁹-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour. Psychopharmacology (Berl). 2012; 219:859-73. doi: 10.1007/s00213-011-2415-0
Authors: Deiana S, Watanabe A, Yamasaki Y, Amada N, Arthur M, Fleming S, Woodcock H, Dorward P, Pigliacampo B, Close S, Platt B, Riedel G
